Wells Fargo’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $519K | Buy |
|
|||||
|
2025
Q2 | $581K | Buy |
|
|||||
|
2025
Q1 | $250K | Buy |
|
|||||
|
2024
Q4 | $233K | Buy |
|
|||||
|
2024
Q3 | $131K | Buy |
|
|||||
|
2024
Q2 | $98K | Buy |
|
|||||
|
2024
Q1 | $14.7K | Sell |
|
|||||
|
2023
Q4 | $13.8K | Buy |
|
|||||
|
2023
Q3 | $12.6K | Sell |
|
|||||
|
2023
Q2 | $10.2K | Sell |
|
|||||
|
2023
Q1 | $6.87K | Sell |
|
|||||
|
2022
Q4 | $7.78K | Sell |
|
|||||
|
2022
Q3 | $4K | Sell |
|
|||||
|
2022
Q2 | $4K | Sell |
|
|||||
|
2022
Q1 | $212K | Sell |
|
|||||
|
2021
Q4 | $787K | Buy |
|
|||||
|
2021
Q3 | $421K | Buy |
|
|||||
|
2021
Q2 | $75K | Sell |
|
|||||
|
2021
Q1 | $367K | Sell |
|
|||||
|
2020
Q4 | $730K | Sell |
|
|||||
|
2020
Q3 | $782K | Buy |
|
|||||
|
2020
Q2 | $4.16M | Buy |
|
|||||
|
2020
Q1 | $1.84M | Buy |
|
|||||
|
2019
Q4 | $1.28M | Sell |
|
|||||
|
2019
Q3 | $798K | Buy |
|
|||||
|
2019
Q2 | $820K | Buy |
|
|||||
|
2019
Q1 | $1.22M | Sell |
|
|||||
|
2018
Q4 | $878K | Buy |
|
|||||
|
2018
Q3 | $694K | Sell |
|
|||||
|
2018
Q2 | $1.19M | Buy |
|
|||||
|
2018
Q1 | $1.09M | Sell |
|
|||||
|
2017
Q4 | $1.8M | Buy |
|
|||||
|
2017
Q3 | $1.75M | Buy |
|
|||||
|
2017
Q2 | $1.27M | Buy |
|
|||||
|
2017
Q1 | $802K | Sell |
|
|||||
|
2016
Q4 | $926K | Buy |
|
|||||
|
2016
Q3 | $761K | Buy |
|
|||||
|
2016
Q2 | $621K | Sell |
|
|||||
|
2016
Q1 | $784K | Sell |
|
|||||
|
2015
Q4 | $1.19M | Buy |
|
|||||
|
2015
Q3 | $128K | Buy |
|
|||||
|
2015
Q2 | $84K | Buy |
|
|||||
|
2015
Q1 | $91K | Buy |
|
|||||
|
2014
Q4 | $80K | Buy |
|
|||||
|
2014
Q3 | $29K | Sell |
|
|||||
|
2014
Q2 | $96K | Buy |
|